C21ORF63-CBR3 Fusion FISH Probe
The C21ORF63-CBR3 Fusion FISH Probe is used to confirm a fusion of the C21ORF63 and CBR3 genes. The fusion of the C21ORF63 and CBR3 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| C21ORF63-CBR3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| C21ORF63-CBR3-20-AQAQ | 20 (40 μL) | 200 μL |
|
CBR3 Gene Summary
Carbonyl reductase 3 catalyzes the reduction of a large number of biologically and pharmacologically active carbonyl compounds to their corresponding alcohols. The enzyme is classified as a monomeric NADPH-dependent oxidoreductase. CBR3 contains three exons spanning 11.2 kilobases and is closely linked to another carbonyl reductase gene - CBR1. [provided by RefSeq, Jul 2008]
Gene Name: Carbonyl Reductase 3
Chromosome: CHR21: 37507262 -37518860
Locus: 21q22.12
Gene Diseases
The C21ORF63 CBR3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|